Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-02 @ 1:20 AM
Study NCT ID:
NCT00771667
Status:
COMPLETED
Last Update Posted:
2013-04-01
First Post:
2008-10-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
Sponsor:
Centocor, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12
Start Date Type:
None
Primary Completion Date:
2010-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-10
First Submit QC Date:
None
Study First Post Date:
2008-10-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-10-10
Results First Submit QC Date:
None
Results First Post Date:
2012-07-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-05-03
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-03-26
Last Update Post Date:
2013-04-01
Last Update Post Date Type:
ESTIMATED